Boston Scientific Corporation (BSX)
Medical - Devices · Healthcare · $63.4B
Intrinsic Value (Consensus)
$28.37
Current Price
$45.30
Margin of Safety
-37.4%
37.4% Above Intrinsic Value
Value: $28
Price: $45
Valuation Model Estimates
Current Price: $45.30
DCF (Discounted Cash Flow)
$122.59
Graham Number
$27.49
Earnings Power Value
$18.83
Relative Value (P/E)
$38.80
Dividend Discount Model
Not applicable
—
Consensus Value
$28.37
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
61
Profitability
10/25
Strength
25/25
Valuation
7/25
Growth
19/25
Financial Health Signals
Negative return on equity — company is losing money on shareholder capital
Low debt — conservative balance sheet
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $1.94
- EPS (Forward)
- $2.33
- Book Value
- $17.32
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- -5.4%
- Debt/Equity
- 16%
- Revenue Growth
- 19.9%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 0.56
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance